| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DVA - DaVita HealthCare Partners Inc | SELL | -50 @ USD 149.49 | USD -7,475 | The ETF sold 50 shares of DVA on 2025-04-04. The shares were previously bought for an average price of USD 156.212. The DaVita HealthCare Partners Inc shares were sold for -4.3% lower than average price of previous purchases. This resulted in an overall loss of USD 336 The average price that the ETF previously sold DVA share for is USD 155.359 which is higher than the selling price of USD 149.49 on 2025-04-04. |
| CRL - Creightons Plc | SELL | -56 @ USD 136.9 | USD -7,666 | The ETF sold 56 shares of CRL on 2025-04-04. The shares were previously bought for an average price of USD 171.177. The Creightons Plc shares were sold for -20.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,920 The average price that the ETF previously sold CRL share for is USD 197.616 which is higher than the selling price of USD 136.9 on 2025-04-04. |
| HSIC - Henry Schein Inc | SELL | -134 @ USD 65.47 | USD -8,773 | The ETF sold 134 shares of HSIC on 2025-04-04. The shares were previously bought for an average price of USD 73.4903. The Henry Schein Inc shares were sold for -10.9% lower than average price of previous purchases. This resulted in an overall loss of USD 1,075 The average price that the ETF previously sold HSIC share for is USD 72.2396 which is higher than the selling price of USD 65.47 on 2025-04-04. |
| TECH - Bio-Techne Corp | SELL | -170 @ USD 51.72 | USD -8,792 | The ETF sold 170 shares of TECH on 2025-04-04. The shares were previously bought for an average price of USD 67.0223. The Bio-Techne Corp shares were sold for -22.8% lower than average price of previous purchases. This resulted in an overall loss of USD 2,601 The average price that the ETF previously sold TECH share for is USD 72.6198 which is higher than the selling price of USD 51.72 on 2025-04-04. |
| MRNA - Moderna Inc | SELL | -356 @ USD 25.11 | USD -8,939 | The ETF sold 356 shares of MRNA on 2025-04-04. The shares were previously bought for an average price of USD 36.4077. The Moderna Inc shares were sold for -31.0% lower than average price of previous purchases. This resulted in an overall loss of USD 4,022 The average price that the ETF previously sold MRNA share for is USD 43.3066 which is higher than the selling price of USD 25.11 on 2025-04-04. |
| SOLV - Solventum Corp. | SELL | -144 @ USD 66.2 | USD -9,533 | The ETF sold 144 shares of SOLV on 2025-04-04. The shares were previously bought for an average price of USD 74.7865. The Solventum Corp. shares were sold for -11.5% lower than average price of previous purchases. This resulted in an overall loss of USD 1,236 The average price that the ETF previously sold SOLV share for is USD 71.6574 which is higher than the selling price of USD 66.2 on 2025-04-04. |
| VTRS - Viatris Inc | SELL | -1,292 @ USD 7.62 | USD -9,845 | The ETF sold 1292 shares of VTRS on 2025-04-04. The shares were previously bought for an average price of USD 10.5684. The Viatris Inc shares were sold for -27.9% lower than average price of previous purchases. This resulted in an overall loss of USD 3,809 The average price that the ETF previously sold VTRS share for is USD 12.5445 which is higher than the selling price of USD 7.62 on 2025-04-04. |
| INCY - Incyte Corporation | SELL | -174 @ USD 60.58 | USD -10,541 | The ETF sold 174 shares of INCY on 2025-04-04. The shares were previously bought for an average price of USD 69.7854. The Incyte Corporation shares were sold for -13.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,602 The average price that the ETF previously sold INCY share for is USD 74.8602 which is higher than the selling price of USD 60.58 on 2025-04-04. |
| UHS - Universal Health Services Inc | SELL | -62 @ USD 174.53 | USD -10,821 | The ETF sold 62 shares of UHS on 2025-04-04. The shares were previously bought for an average price of USD 190.165. The Universal Health Services Inc shares were sold for -8.2% lower than average price of previous purchases. This resulted in an overall loss of USD 969 The average price that the ETF previously sold UHS share for is USD 197.437 which is higher than the selling price of USD 174.53 on 2025-04-04. |
| ALGN - Align Technology Inc | SELL | -78 @ USD 153.51 | USD -11,974 | The ETF sold 78 shares of ALGN on 2025-04-04. The shares were previously bought for an average price of USD 190.424. The Align Technology Inc shares were sold for -19.4% lower than average price of previous purchases. This resulted in an overall loss of USD 2,879 The average price that the ETF previously sold ALGN share for is USD 222.351 which is higher than the selling price of USD 153.51 on 2025-04-04. |
| RVTY - Revvity Inc. | SELL | -134 @ USD 94.84 | USD -12,709 | The ETF sold 134 shares of RVTY on 2025-04-04. The shares were previously bought for an average price of USD 113.763. The Revvity Inc. shares were sold for -16.6% lower than average price of previous purchases. This resulted in an overall loss of USD 2,536 The average price that the ETF previously sold RVTY share for is USD 117.037 which is higher than the selling price of USD 94.84 on 2025-04-04. |
| HOLX - Hologic Inc | SELL | -242 @ USD 60.86 | USD -14,728 | The ETF sold 242 shares of HOLX on 2025-04-04. The shares were previously bought for an average price of USD 67.8373. The Hologic Inc shares were sold for -10.3% lower than average price of previous purchases. This resulted in an overall loss of USD 1,689 The average price that the ETF previously sold HOLX share for is USD 73.5535 which is higher than the selling price of USD 60.86 on 2025-04-04. |
| BAX - Baxter International Inc | SELL | -548 @ USD 28.79 | USD -15,777 | The ETF sold 548 shares of BAX on 2025-04-04. The shares were previously bought for an average price of USD 33.5164. The Baxter International Inc shares were sold for -14.1% lower than average price of previous purchases. This resulted in an overall loss of USD 2,590 The average price that the ETF previously sold BAX share for is USD 33.6211 which is higher than the selling price of USD 28.79 on 2025-04-04. |
| WST - West Pharmaceutical Services Inc | SELL | -78 @ USD 203.21 | USD -15,850 | The ETF sold 78 shares of WST on 2025-04-04. The shares were previously bought for an average price of USD 264.303. The West Pharmaceutical Services Inc shares were sold for -23.1% lower than average price of previous purchases. This resulted in an overall loss of USD 4,765 The average price that the ETF previously sold WST share for is USD 308.039 which is higher than the selling price of USD 203.21 on 2025-04-04. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -220 @ USD 73.77 | USD -16,229 | The ETF sold 220 shares of COO on 2025-04-04. The shares were previously bought for an average price of USD 89.8782. The The Cooper Companies, Inc. Common Stock shares were sold for -17.9% lower than average price of previous purchases. This resulted in an overall loss of USD 3,544 The average price that the ETF previously sold COO share for is USD 99.5262 which is higher than the selling price of USD 73.77 on 2025-04-04. |
| PODD - Insulet Corporation | SELL | -76 @ USD 245.26 | USD -18,640 | The ETF sold 76 shares of PODD on 2025-04-04. The shares were previously bought for an average price of USD 269.561. The Insulet Corporation shares were sold for -9.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,847 The average price that the ETF previously sold PODD share for is USD 262.469 which is higher than the selling price of USD 245.26 on 2025-04-04. |
| BIIB - Biogen Inc | SELL | -158 @ USD 122.98 | USD -19,431 | The ETF sold 158 shares of BIIB on 2025-04-04. The shares were previously bought for an average price of USD 147.936. The Biogen Inc shares were sold for -16.9% lower than average price of previous purchases. This resulted in an overall loss of USD 3,943 The average price that the ETF previously sold BIIB share for is USD 162.445 which is higher than the selling price of USD 122.98 on 2025-04-04. |
| DGX - Quest Diagnostics Incorporated | SELL | -122 @ USD 164.18 | USD -20,030 | The ETF sold 122 shares of DGX on 2025-04-04. The shares were previously bought for an average price of USD 165.734. The Quest Diagnostics Incorporated shares were sold for -0.9% lower than average price of previous purchases. This resulted in an overall loss of USD 190 The average price that the ETF previously sold DGX share for is USD 160.881 so the ETF has sold 122 shares on 2025-04-04 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -90 @ USD 225 | USD -20,250 | The ETF sold 90 shares of LH on 2025-04-04. The shares were previously bought for an average price of USD 241.657. The Laboratory Corporation of America Holdings shares were sold for -6.9% lower than average price of previous purchases. This resulted in an overall loss of USD 1,499 The average price that the ETF previously sold LH share for is USD 238.589 which is higher than the selling price of USD 225 on 2025-04-04. |
| WAT - Waters Corporation | SELL | -64 @ USD 324.92 | USD -20,795 | The ETF sold 64 shares of WAT on 2025-04-04. The shares were previously bought for an average price of USD 373.416. The Waters Corporation shares were sold for -13.0% lower than average price of previous purchases. This resulted in an overall loss of USD 3,104 The average price that the ETF previously sold WAT share for is USD 377.601 which is higher than the selling price of USD 324.92 on 2025-04-04. |
| WAT - MULETFWATIMETFP | SELL | -64 @ USD 324.92 | USD -20,795 | The ETF sold 64 shares of WAT on 2025-04-04. The shares were previously bought for an average price of USD 373.416. The MULETFWATIMETFP shares were sold for -13.0% lower than average price of previous purchases. This resulted in an overall loss of USD 3,104 The average price that the ETF previously sold WAT share for is USD 377.601 which is higher than the selling price of USD 324.92 on 2025-04-04. |
| MOH - MOH | SELL | -60 @ USD 346.71 | USD -20,803 | The ETF sold 60 shares of MOH on 2025-04-04. The shares were previously bought for an average price of USD 307.818. The MOH shares were sold for 12.6% higher than average price of previous purchases. This sale made a profit of USD 2,334 The average price that the ETF previously sold MOH share for is USD 312.012 so the ETF has sold 60 shares on 2025-04-04 at a higher price than the previous selling average. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -60 @ USD 346.71 | USD -20,803 | The ETF sold 60 shares of MOH on 2025-04-04. The shares were previously bought for an average price of USD 307.818. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for 12.6% higher than average price of previous purchases. This sale made a profit of USD 2,334 The average price that the ETF previously sold MOH share for is USD 312.012 so the ETF has sold 60 shares on 2025-04-04 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -22 @ USD 1022.66 | USD -22,499 | The ETF sold 22 shares of MTD on 2025-04-04. The shares were previously bought for an average price of USD 1258.05. The Mettler-Toledo International Inc shares were sold for -18.7% lower than average price of previous purchases. This resulted in an overall loss of USD 5,179 The average price that the ETF previously sold MTD share for is USD 1262.16 which is higher than the selling price of USD 1022.66 on 2025-04-04. |
| MTD - AMUNDI EUR GOV 710 | SELL | -22 @ USD 1022.66 | USD -22,499 | The ETF sold 22 shares of MTD on 2025-04-04. The shares were previously bought for an average price of USD 1258.05. The AMUNDI EUR GOV 710 shares were sold for -18.7% lower than average price of previous purchases. This resulted in an overall loss of USD 5,179 The average price that the ETF previously sold MTD share for is USD 1262.16 which is higher than the selling price of USD 1022.66 on 2025-04-04. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -212 @ USD 107.34 | USD -22,756 | The ETF sold 212 shares of ZBH on 2025-04-04. The shares were previously bought for an average price of USD 107.997. The Zimmer Biomet Holdings Inc shares were sold for -0.6% lower than average price of previous purchases. This resulted in an overall loss of USD 139 The average price that the ETF previously sold ZBH share for is USD 109.243 which is higher than the selling price of USD 107.34 on 2025-04-04. |
| STE - STERIS plc | SELL | -108 @ USD 212.61 | USD -22,962 | The ETF sold 108 shares of STE on 2025-04-04. The shares were previously bought for an average price of USD 221.717. The STERIS plc shares were sold for -4.1% lower than average price of previous purchases. This resulted in an overall loss of USD 984 The average price that the ETF previously sold STE share for is USD 218.126 which is higher than the selling price of USD 212.61 on 2025-04-04. |
| DXCM - DexCom Inc | SELL | -424 @ USD 59.83 | USD -25,368 | The ETF sold 424 shares of DXCM on 2025-04-04. The shares were previously bought for an average price of USD 78.5289. The DexCom Inc shares were sold for -23.8% lower than average price of previous purchases. This resulted in an overall loss of USD 7,928 The average price that the ETF previously sold DXCM share for is USD 74.5556 which is higher than the selling price of USD 59.83 on 2025-04-04. |
| IQV - IQVIA Holdings Inc | SELL | -182 @ USD 154.73 | USD -28,161 | The ETF sold 182 shares of IQV on 2025-04-04. The shares were previously bought for an average price of USD 196.411. The IQVIA Holdings Inc shares were sold for -21.2% lower than average price of previous purchases. This resulted in an overall loss of USD 7,586 The average price that the ETF previously sold IQV share for is USD 202.595 which is higher than the selling price of USD 154.73 on 2025-04-04. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -492 @ USD 60.51 | USD -29,771 | The ETF sold 492 shares of GEHC on 2025-04-04. The shares were previously bought for an average price of USD 86.443. The GE HealthCare Technologies Inc. shares were sold for -30.0% lower than average price of previous purchases. This resulted in an overall loss of USD 12,759 The average price that the ETF previously sold GEHC share for is USD 83.7004 which is higher than the selling price of USD 60.51 on 2025-04-04. |
| A - Agilent Technologies Inc | SELL | -310 @ USD 103 | USD -31,930 | The ETF sold 310 shares of A on 2025-04-04. The shares were previously bought for an average price of USD 131.964. The Agilent Technologies Inc shares were sold for -21.9% lower than average price of previous purchases. This resulted in an overall loss of USD 8,979 The average price that the ETF previously sold A share for is USD 134.973 which is higher than the selling price of USD 103 on 2025-04-04. |
| RMD - ResMed Inc | SELL | -160 @ USD 205.17 | USD -32,827 | The ETF sold 160 shares of RMD on 2025-04-04. The shares were previously bought for an average price of USD 235.04. The ResMed Inc shares were sold for -12.7% lower than average price of previous purchases. This resulted in an overall loss of USD 4,779 The average price that the ETF previously sold RMD share for is USD 244.785 which is higher than the selling price of USD 205.17 on 2025-04-04. |
| HUM - Hummingbird Resources PLC | SELL | -130 @ USD 253.77 | USD -32,990 | The ETF sold 130 shares of HUM on 2025-04-04. The shares were previously bought for an average price of USD 272.131. The Hummingbird Resources PLC shares were sold for -6.7% lower than average price of previous purchases. This resulted in an overall loss of USD 2,387 The average price that the ETF previously sold HUM share for is USD 283.407 which is higher than the selling price of USD 253.77 on 2025-04-04. |
| HUM - Humana Inc | SELL | -130 @ USD 253.77 | USD -32,990 | The ETF sold 130 shares of HUM on 2025-04-04. The shares were previously bought for an average price of USD 272.131. The Humana Inc shares were sold for -6.7% lower than average price of previous purchases. This resulted in an overall loss of USD 2,387 The average price that the ETF previously sold HUM share for is USD 283.407 which is higher than the selling price of USD 253.77 on 2025-04-04. |
| CNC - Concurrent Technologies Plc | SELL | -542 @ USD 61.93 | USD -33,566 | The ETF sold 542 shares of CNC on 2025-04-04. The shares were previously bought for an average price of USD 60.1823. The Concurrent Technologies Plc shares were sold for 2.9% higher than average price of previous purchases. This sale made a profit of USD 947 The average price that the ETF previously sold CNC share for is USD 59.7137 so the ETF has sold 542 shares on 2025-04-04 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -264 @ USD 129.63 | USD -34,222 | The ETF sold 264 shares of CAH on 2025-04-04. The shares were previously bought for an average price of USD 127.212. The Cardinal Health Inc shares were sold for 1.9% higher than average price of previous purchases. This sale made a profit of USD 638 The average price that the ETF previously sold CAH share for is USD 121.975 so the ETF has sold 264 shares on 2025-04-04 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -88 @ USD 393.73 | USD -34,648 | The ETF sold 88 shares of IDXX on 2025-04-04. The shares were previously bought for an average price of USD 438.202. The IDEXX Laboratories Inc shares were sold for -10.1% lower than average price of previous purchases. This resulted in an overall loss of USD 3,914 The average price that the ETF previously sold IDXX share for is USD 431.236 which is higher than the selling price of USD 393.73 on 2025-04-04. |
| EW - Edwards Lifesciences Corp | SELL | -640 @ USD 69.36 | USD -44,390 | The ETF sold 640 shares of EW on 2025-04-04. The shares were previously bought for an average price of USD 71.0156. The Edwards Lifesciences Corp shares were sold for -2.3% lower than average price of previous purchases. This resulted in an overall loss of USD 1,060 The average price that the ETF previously sold EW share for is USD 69.3794 which is higher than the selling price of USD 69.36 on 2025-04-04. |
| COR - Cencora Inc. | SELL | -188 @ USD 278.39 | USD -52,337 | The ETF sold 188 shares of COR on 2025-04-04. The shares were previously bought for an average price of USD 251.231. The Cencora Inc. shares were sold for 10.8% higher than average price of previous purchases. This sale made a profit of USD 5,106 The average price that the ETF previously sold COR share for is USD 247.024 so the ETF has sold 188 shares on 2025-04-04 at a higher price than the previous selling average. |
| HCA - HCA Holdings Inc | SELL | -194 @ USD 331.65 | USD -64,340 | The ETF sold 194 shares of HCA on 2025-04-04. The shares were previously bought for an average price of USD 336.277. The HCA Holdings Inc shares were sold for -1.4% lower than average price of previous purchases. This resulted in an overall loss of USD 898 The average price that the ETF previously sold HCA share for is USD 335.671 which is higher than the selling price of USD 331.65 on 2025-04-04. |
| BDX - Becton Dickinson and Company | SELL | -312 @ USD 207.34 | USD -64,690 | The ETF sold 312 shares of BDX on 2025-04-04. The shares were previously bought for an average price of USD 231.159. The Becton Dickinson and Company shares were sold for -10.3% lower than average price of previous purchases. This resulted in an overall loss of USD 7,432 The average price that the ETF previously sold BDX share for is USD 226.682 which is higher than the selling price of USD 207.34 on 2025-04-04. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -114 @ USD 573.45 | USD -65,373 | The ETF sold 114 shares of REGN on 2025-04-04. The shares were previously bought for an average price of USD 714.539. The Regeneron Pharmaceuticals Inc shares were sold for -19.7% lower than average price of previous purchases. This resulted in an overall loss of USD 16,084 The average price that the ETF previously sold REGN share for is USD 779.834 which is higher than the selling price of USD 573.45 on 2025-04-04. |
| ZTS - Zoetis Inc | SELL | -486 @ USD 151.73 | USD -73,741 | The ETF sold 486 shares of ZTS on 2025-04-04. The shares were previously bought for an average price of USD 168.289. The Zoetis Inc shares were sold for -9.8% lower than average price of previous purchases. This resulted in an overall loss of USD 8,048 The average price that the ETF previously sold ZTS share for is USD 176.246 which is higher than the selling price of USD 151.73 on 2025-04-04. |
| CVS - CVS Health Corp | SELL | -1,368 @ USD 63.66 | USD -87,087 | The ETF sold 1368 shares of CVS on 2025-04-04. The shares were previously bought for an average price of USD 62.1919. The CVS Health Corp shares were sold for 2.4% higher than average price of previous purchases. This sale made a profit of USD 2,008 The average price that the ETF previously sold CVS share for is USD 57.5613 so the ETF has sold 1368 shares on 2025-04-04 at a higher price than the previous selling average. |
| MCK - McKesson Corporation | SELL | -136 @ USD 683.11 | USD -92,903 | The ETF sold 136 shares of MCK on 2025-04-04. The shares were previously bought for an average price of USD 612.44. The McKesson Corporation shares were sold for 11.5% higher than average price of previous purchases. This sale made a profit of USD 9,611 The average price that the ETF previously sold MCK share for is USD 607.889 so the ETF has sold 136 shares on 2025-04-04 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -298 @ USD 322.4 | USD -96,075 | The ETF sold 298 shares of CI on 2025-04-04. The shares were previously bought for an average price of USD 313.959. The Cigna Corp shares were sold for 2.7% higher than average price of previous purchases. This sale made a profit of USD 2,515 The average price that the ETF previously sold CI share for is USD 322.663 which is higher than the selling price of USD 322.4 on 2025-04-04. |
| ELV - Elevance Health Inc | SELL | -252 @ USD 428.89 | USD -108,080 | The ETF sold 252 shares of ELV on 2025-04-04. The shares were previously bought for an average price of USD 409.68. The Elevance Health Inc shares were sold for 4.7% higher than average price of previous purchases. This sale made a profit of USD 4,841 The average price that the ETF previously sold ELV share for is USD 409.676 so the ETF has sold 252 shares on 2025-04-04 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -252 @ USD 428.89 | USD -108,080 | The ETF sold 252 shares of ELV on 2025-04-04. The shares were previously bought for an average price of USD 409.68. The Elevance Health Inc shares were sold for 4.7% higher than average price of previous purchases. This sale made a profit of USD 4,841 The average price that the ETF previously sold ELV share for is USD 409.676 so the ETF has sold 252 shares on 2025-04-04 at a higher price than the previous selling average. |
| MDT - Medtronic PLC | SELL | -1,394 @ USD 82.88 | USD -115,535 | The ETF sold 1394 shares of MDT on 2025-04-04. The shares were previously bought for an average price of USD 89.1446. The Medtronic PLC shares were sold for -7.0% lower than average price of previous purchases. This resulted in an overall loss of USD 8,733 The average price that the ETF previously sold MDT share for is USD 86.8991 which is higher than the selling price of USD 82.88 on 2025-04-04. |
| BMY - Bloomsbury Publishing Plc | SELL | -2,204 @ USD 55.3 | USD -121,881 | The ETF sold 2204 shares of BMY on 2025-04-04. The shares were previously bought for an average price of USD 58.1196. The Bloomsbury Publishing Plc shares were sold for -4.9% lower than average price of previous purchases. This resulted in an overall loss of USD 6,214 The average price that the ETF previously sold BMY share for is USD 57.2071 which is higher than the selling price of USD 55.3 on 2025-04-04. |
| DHR - Danaher Corporation | SELL | -696 @ USD 181.77 | USD -126,512 | The ETF sold 696 shares of DHR on 2025-04-04. The shares were previously bought for an average price of USD 219.847. The Danaher Corporation shares were sold for -17.3% lower than average price of previous purchases. This resulted in an overall loss of USD 26,502 The average price that the ETF previously sold DHR share for is USD 236.669 which is higher than the selling price of USD 181.77 on 2025-04-04. |
| DHR - Danaher Corporation | SELL | -696 @ USD 181.77 | USD -126,512 | The ETF sold 696 shares of DHR on 2025-04-04. The shares were previously bought for an average price of USD 219.847. The Danaher Corporation shares were sold for -17.3% lower than average price of previous purchases. This resulted in an overall loss of USD 26,502 The average price that the ETF previously sold DHR share for is USD 236.669 which is higher than the selling price of USD 181.77 on 2025-04-04. |
| SYK - Stryker Corporation | SELL | -374 @ USD 345.8 | USD -129,329 | The ETF sold 374 shares of SYK on 2025-04-04. The shares were previously bought for an average price of USD 380.929. The Stryker Corporation shares were sold for -9.2% lower than average price of previous purchases. This resulted in an overall loss of USD 13,138 The average price that the ETF previously sold SYK share for is USD 380.282 which is higher than the selling price of USD 345.8 on 2025-04-04. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -278 @ USD 474.62 | USD -131,944 | The ETF sold 278 shares of VRTX on 2025-04-04. The shares were previously bought for an average price of USD 477.045. The Vertex Pharmaceuticals Inc shares were sold for -0.5% lower than average price of previous purchases. This resulted in an overall loss of USD 674 The average price that the ETF previously sold VRTX share for is USD 481.05 which is higher than the selling price of USD 474.62 on 2025-04-04. |
| PFE - Pfizer Inc | SELL | -6,150 @ USD 22.97 | USD -141,266 | The ETF sold 6150 shares of PFE on 2025-04-04. The shares were previously bought for an average price of USD 26.0678. The Pfizer Inc shares were sold for -11.9% lower than average price of previous purchases. This resulted in an overall loss of USD 19,051 The average price that the ETF previously sold PFE share for is USD 26.1508 which is higher than the selling price of USD 22.97 on 2025-04-04. |
| BSX - Boston Scientific Corporation | SELL | -1,602 @ USD 89.7 | USD -143,699 | The ETF sold 1602 shares of BSX on 2025-04-04. The shares were previously bought for an average price of USD 98.4985. The Boston Scientific Corporation shares were sold for -8.9% lower than average price of previous purchases. This resulted in an overall loss of USD 14,095 The average price that the ETF previously sold BSX share for is USD 90.0233 which is higher than the selling price of USD 89.7 on 2025-04-04. |
| BSX - MULSTRXSSXIMETFP | SELL | -1,602 @ USD 89.7 | USD -143,699 | The ETF sold 1602 shares of BSX on 2025-04-04. The shares were previously bought for an average price of USD 98.4985. The MULSTRXSSXIMETFP shares were sold for -8.9% lower than average price of previous purchases. This resulted in an overall loss of USD 14,095 The average price that the ETF previously sold BSX share for is USD 90.0233 which is higher than the selling price of USD 89.7 on 2025-04-04. |
| GILD - Guild Esports Plc | SELL | -1,352 @ USD 107.25 | USD -145,002 | The ETF sold 1352 shares of GILD on 2025-04-04. The shares were previously bought for an average price of USD 102.556. The Guild Esports Plc shares were sold for 4.6% higher than average price of previous purchases. This sale made a profit of USD 6,346 The average price that the ETF previously sold GILD share for is USD 94.1875 so the ETF has sold 1352 shares on 2025-04-04 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -584 @ USD 294.39 | USD -171,924 | The ETF sold 584 shares of AMGN on 2025-04-04. The shares were previously bought for an average price of USD 304.248. The Amgen Inc shares were sold for -3.2% lower than average price of previous purchases. This resulted in an overall loss of USD 5,757 The average price that the ETF previously sold AMGN share for is USD 298.358 which is higher than the selling price of USD 294.39 on 2025-04-04. |
| ISRG - Intuitive Surgical Inc | SELL | -388 @ USD 451.58 | USD -175,213 | The ETF sold 388 shares of ISRG on 2025-04-04. The shares were previously bought for an average price of USD 546.225. The Intuitive Surgical Inc shares were sold for -17.3% lower than average price of previous purchases. This resulted in an overall loss of USD 36,722 The average price that the ETF previously sold ISRG share for is USD 534.62 which is higher than the selling price of USD 451.58 on 2025-04-04. |
| TMO - Time Out Group plc | SELL | -416 @ USD 437.91 | USD -182,171 | The ETF sold 416 shares of TMO on 2025-04-04. The shares were previously bought for an average price of USD 532.898. The Time Out Group plc shares were sold for -17.8% lower than average price of previous purchases. This resulted in an overall loss of USD 39,515 The average price that the ETF previously sold TMO share for is USD 532.869 which is higher than the selling price of USD 437.91 on 2025-04-04. |
| MRK - Marks Electrical Group PLC | SELL | -2,750 @ USD 81.47 | USD -224,043 | The ETF sold 2750 shares of MRK on 2025-04-04. The shares were previously bought for an average price of USD 93.1573. The Marks Electrical Group PLC shares were sold for -12.5% lower than average price of previous purchases. This resulted in an overall loss of USD 32,140 The average price that the ETF previously sold MRK share for is USD 100.759 which is higher than the selling price of USD 81.47 on 2025-04-04. |
| MRK - Merck & Company Inc | SELL | -2,750 @ USD 81.47 | USD -224,043 | The ETF sold 2750 shares of MRK on 2025-04-04. The shares were previously bought for an average price of USD 93.1573. The Merck & Company Inc shares were sold for -12.5% lower than average price of previous purchases. This resulted in an overall loss of USD 32,140 The average price that the ETF previously sold MRK share for is USD 100.759 which is higher than the selling price of USD 81.47 on 2025-04-04. |
| ABT - Abbott Laboratories | SELL | -1,882 @ USD 124.44 | USD -234,196 | The ETF sold 1882 shares of ABT on 2025-04-04. The shares were previously bought for an average price of USD 126.267. The Abbott Laboratories shares were sold for -1.4% lower than average price of previous purchases. This resulted in an overall loss of USD 3,438 The average price that the ETF previously sold ABT share for is USD 117.842 so the ETF has sold 1882 shares on 2025-04-04 at a higher price than the previous selling average. |
| ABBV - AbbVie Inc | SELL | -1,918 @ USD 186.96 | USD -358,589 | The ETF sold 1918 shares of ABBV on 2025-04-04. The shares were previously bought for an average price of USD 193.27. The AbbVie Inc shares were sold for -3.3% lower than average price of previous purchases. This resulted in an overall loss of USD 12,103 The average price that the ETF previously sold ABBV share for is USD 187.066 which is higher than the selling price of USD 186.96 on 2025-04-04. |
| JNJ - Johnson & Johnson | SELL | -2,616 @ USD 153.24 | USD -400,876 | The ETF sold 2616 shares of JNJ on 2025-04-04. The shares were previously bought for an average price of USD 157.739. The Johnson & Johnson shares were sold for -2.9% lower than average price of previous purchases. This resulted in an overall loss of USD 11,769 The average price that the ETF previously sold JNJ share for is USD 155.033 which is higher than the selling price of USD 153.24 on 2025-04-04. |
| UNH - UnitedHealth Group Incorporated | SELL | -1,000 @ USD 525.05 | USD -525,050 | The ETF sold 1000 shares of UNH on 2025-04-04. The shares were previously bought for an average price of USD 535.348. The UnitedHealth Group Incorporated shares were sold for -1.9% lower than average price of previous purchases. This resulted in an overall loss of USD 10,298 The average price that the ETF previously sold UNH share for is USD 583.654 which is higher than the selling price of USD 525.05 on 2025-04-04. |
| LLY - Eli Lilly and Company | SELL | -856 @ USD 738.21 | USD -631,908 | The ETF sold 856 shares of LLY on 2025-04-04. The shares were previously bought for an average price of USD 838.12. The Eli Lilly and Company shares were sold for -11.9% lower than average price of previous purchases. This resulted in an overall loss of USD 85,523 The average price that the ETF previously sold LLY share for is USD 805.039 which is higher than the selling price of USD 738.21 on 2025-04-04. |